Physician
Roper ST Francis Hospital-Berkeley INC.
Roper ST Francis Hospital-Berkeley INC. was paid $7.33M by Medicaid between Oct 2019 and Dec 2024, across 156 billing codes. Its largest line is 99283, emergency room visit (moderate) — 13% of everything it billed.
33Billing provider infoROPER ST FRANCIS HOSPITAL-BERKELEY INC.
SUMMERVILLE, SC 29486
SUMMERVILLE, SC 29486
33aNPI1336603646assigned 01/31/2019
33bProvider typeCritical Care Medicine (Internal Medicine) Physician
28Total paid$7.33M
24GClaims284,758
24DCodes billed156
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other Critical Care Medicine (Internal Medicine) Physician providers in South Carolina
Rank by total paid#2 of 17
Median peer was paid$68K
This provider vs. median107×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 5,140 | $76K | |
| 2020 | 33,871 | $596K | |
| 2021 | 50,616 | $1.05M | |
| 2022 | 57,250 | $1.91M | |
| 2023 | 71,173 | $2.10M | |
| 2024incomplete | 66,708 | $1.60M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 22,714 | 20,548 | $943K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 8.5% | 5,866 | 5,343 | $623K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 7.5% | 8,841 | 7,836 | $547K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.7% | 4,103 | 3,816 | $489K |
| 80048 | Basic metabolic panel (calcium, ionized) | 6.2% | 10,483 | 9,125 | $455K |
| 80053 | Comprehensive metabolic panel | 5.9% | 10,938 | 9,621 | $436K |
| 81003 | 4.1% | 9,460 | 8,598 | $299K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3.2% | 1,624 | 1,495 | $234K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3.1% | 1,912 | 1,772 | $227K |
| 36415 | Collection of venous blood by venipuncture | 2.8% | 3,490 | 3,020 | $205K |
| 81025 | 2.5% | 8,380 | 7,606 | $185K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.4% | 4,051 | 3,469 | $179K |
144 more codes
| 81001 | 2.4% | 6,446 | $174K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.1% | 1,517 | $155K |
| 99284 | Emergency room visit (serious) | 1.9% | 16,573 | $140K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.6% | 3,955 | $117K |
| 87210 | 1.6% | 1,652 | $116K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.4% | 3,564 | $100K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.2% | 2,850 | $86K |
| 86901 | 1.1% | 1,692 | $84K | |
| 84132 | 1.0% | 707 | $75K | |
| 87430 | <1% | 1,788 | $72K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,078 | $70K |
| J3490 | Unclassified drugs | <1% | 640 | $68K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,675 | $63K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 392 | $61K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,536 | $60K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 482 | $55K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,649 | $53K |
| 84702 | <1% | 1,752 | $50K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,268 | $50K |
| 73630 | <1% | 705 | $48K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,727 | $47K |
| 99285 | Emergency room visit (most serious) | <1% | 9,122 | $43K |
| 71045 | Radiologic examination, chest; single view | <1% | 6,075 | $40K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,434 | $40K |
| 87040 | <1% | 2,630 | $38K | |
| 73130 | <1% | 385 | $36K | |
| 73562 | <1% | 658 | $31K | |
| 84484 | <1% | 5,803 | $30K | |
| 73610 | <1% | 387 | $27K | |
| 93971 | <1% | 393 | $26K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,188 | $25K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,195 | $23K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 517 | $20K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 463 | $20K |
| 73030 | <1% | 354 | $19K | |
| 85027 | <1% | 3,451 | $17K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,381 | $17K |
| 87428 | <1% | 117 | $14K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 239 | $14K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 24 | $14K |
| 71250 | <1% | 127 | $14K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,015 | $14K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 67 | $13K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 562 | $13K |
| 59025 | Fetal non-stress test | <1% | 295 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 18,685 | $12K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 526 | $11K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 97 | $11K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 315 | $11K |
| 73110 | <1% | 169 | $11K | |
| 80076 | <1% | 2,170 | $11K | |
| 76830 | Ultrasound, transvaginal | <1% | 482 | $10K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 57 | $9K |
| G0378 | Hospital observation service, per hour | <1% | 1,632 | $9K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 9,022 | $8K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,801 | $7K |
| 72141 | <1% | 27 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 6,052 | $7K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 318 | $6K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 328 | $6K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,778 | $6K |
| 86900 | <1% | 1,689 | $6K | |
| 96376 | <1% | 1,501 | $5K | |
| 72100 | <1% | 180 | $4K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 320 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,923 | $4K |
| 85379 | <1% | 1,814 | $4K | |
| 93976 | <1% | 482 | $3K | |
| 87077 | <1% | 1,176 | $3K | |
| 74018 | <1% | 80 | $3K | |
| 83605 | <1% | 3,445 | $3K | |
| 76536 | <1% | 41 | $2K | |
| 85610 | <1% | 1,740 | $2K | |
| 84439 | <1% | 249 | $2K | |
| 76642 | <1% | 42 | $1K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 26 | $1K |
| 73560 | <1% | 39 | $995.18 | |
| 12011 | <1% | 14 | $968.16 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 14 | $938.15 |
| 73502 | <1% | 72 | $884.64 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 57 | $732.85 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 23 | $732.31 |
| 83880 | <1% | 1,984 | $669.31 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,296 | $665.05 |
| 83690 | <1% | 5,946 | $655.82 | |
| 82550 | <1% | 510 | $601.56 | |
| 77066 | Tomosynthesis, mammo | <1% | 12 | $578.26 |
| 12001 | <1% | 26 | $577.43 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 548 | $550.00 |
| 86140 | <1% | 236 | $449.01 | |
| 83735 | <1% | 3,088 | $366.24 | |
| 80061 | Lipid panel | <1% | 837 | $363.06 |
| G0379 | Direct admission of patient for hospital observation care | <1% | 28 | $288.16 |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 61 | $256.27 |
| 97161 | <1% | 60 | $248.63 | |
| 84703 | <1% | 36 | $202.75 | |
| 82805 | <1% | 15 | $187.31 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 918 | $149.04 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 649 | $40.56 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,813 | $39.33 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,070 | $31.10 |
| 84145 | <1% | 566 | $21.28 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,146 | $19.69 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,319 | $11.50 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 712 | $9.72 |
| 85730 | <1% | 429 | $8.03 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,178 | $7.77 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,258 | $5.46 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 519 | $4.62 |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 67 | $1.96 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 818 | $1.70 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 68 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 28 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 389 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 61 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 62 | $0.00 |
| 87186 | 0% | 195 | $0.00 | |
| 90715 | 0% | 72 | $0.00 | |
| 82570 | 0% | 37 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 82 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 21 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 47 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 114 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 14 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 19 | $0.00 |
| 84100 | 0% | 17 | $0.00 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 0% | 16 | $0.00 |
| 29125 | 0% | 24 | $0.00 | |
| 82009 | 0% | 14 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 45 | $0.00 |
| 86850 | 0% | 398 | $0.00 | |
| 85652 | 0% | 87 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 143 | $0.00 |
| A9270 | Non-covered item or service | 0% | 1,221 | $0.00 |
| 88304 | 0% | 123 | $0.00 | |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 52 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 0% | 20 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 193 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 29 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 131 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 32 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 56 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 13 | $0.00 |
| 82728 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTUCKER, REBECCA (CFO)
| Provider | Location | Paid |
|---|---|---|
| Bon Secours ST. Francis Xavier Hospital, INC. | Charleston, SC | $700K |
| Roper Hospital, INC. | Charleston, SC | $48K |
| Roper Hospital, INC. | Charleston, SC | $13K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.